Omada Health (NASDAQ:OMDA) CFO Steven Cook Sells 6,800 Shares of Stock

Omada Health, Inc. (NASDAQ:OMDA) CFO Steven Cook sold 6,800 shares of the company’s stock in a transaction on Monday, June 15th. The stock was sold at an average price of $17.23, for a total value of $117,164.00. Following the sale, the chief financial officer owned 187,209 shares of the company’s stock, valued at $3,225,611.07. This trade represents a 3.50% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Omada Health Price Performance

Shares of NASDAQ OMDA opened at $17.11 on Wednesday. The stock has a market capitalization of $1.02 billion and a P/E ratio of -63.37. Omada Health, Inc. has a 1-year low of $10.28 and a 1-year high of $26.92. The business has a fifty day moving average price of $15.54 and a 200 day moving average price of $14.80.

Omada Health (NASDAQ:OMDA) last issued its quarterly earnings data on Thursday, May 7th. The company reported ($0.05) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.08) by $0.03. The firm had revenue of $78.05 million during the quarter. Omada Health had a negative return on equity of 1.82% and a negative net margin of 2.22%. As a group, equities research analysts anticipate that Omada Health, Inc. will post -0.01 earnings per share for the current fiscal year.

Institutional Trading of Omada Health

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Quarry LP acquired a new stake in Omada Health in the fourth quarter valued at approximately $29,000. TD Waterhouse Canada Inc. acquired a new stake in shares of Omada Health in the fourth quarter worth approximately $32,000. Raymond James Financial Inc. purchased a new position in Omada Health during the second quarter worth approximately $32,000. Inlight Wealth Management LLC purchased a new position in Omada Health during the fourth quarter worth approximately $45,000. Finally, Strs Ohio lifted its position in Omada Health by 151.0% during the fourth quarter. Strs Ohio now owns 4,267 shares of the company’s stock worth $67,000 after buying an additional 2,567 shares in the last quarter.

Wall Street Analysts Forecast Growth

A number of brokerages recently weighed in on OMDA. Wells Fargo & Company upped their price objective on Omada Health from $17.00 to $18.00 and gave the stock an “equal weight” rating in a research note on Friday, May 8th. BMO Capital Markets decreased their price objective on Omada Health from $27.00 to $18.00 and set an “outperform” rating for the company in a research note on Friday, March 6th. Evercore reiterated an “outperform” rating and issued a $20.00 price target on shares of Omada Health in a research note on Friday, May 8th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Omada Health in a research note on Thursday, June 4th. Finally, Wall Street Zen cut Omada Health from a “buy” rating to a “hold” rating in a research note on Saturday, May 30th. Ten investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $22.91.

About Omada Health

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.